Skip to main content

Medicare expects to spend $3.5B on new Alzheimer's drug in 2025

By STAT News  
   April 11, 2024

Medicare's actuaries expect the drug Leqembi to cost the traditional Medicare program around $550 million in 2024 and the entire Medicare program $3.5 billion in 2025.

Full story

Get the latest on healthcare leadership in your inbox.